Promoter-Associated Long Noncoding RNAs Repress Transcription Through a RNA Binding Protein TLS

  • Riki Kurokawa
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 722)


The majority of the human genome is found to be transcribed and generates mostly noncoding (nc) RNAs that do not possess protein information. MicroRNAs are one of the well-identified small ncRNAs, but occupy merely a fraction of ncRNAs. Long (large) ncRNAs are emerging as a novel class of ncRNAs, but knowledge of these ncRNAs is far less accumulated. Long ncRNAs are tentatively classified as an ncRNA species containing more than 200 nucleotides. Recently, a long promoter-associated ncRNA (pncRNA) has been identified to be transcribed from the cyclin D1 promoter upon induction by genotoxic factors like ionizing-irradiation. The cyclin D1 pncRNA is specifically bound with an RNA-binding protein TLS (Translocated in liposarcoma) and exerts transcriptional repression through histone acetyltransferase (HAT) inhibitory activity. Analysis of TLS and the pncRNAs could provide a model for elucidating their roles inregulation of mammalian transcriptional programs. The pncRNA binding to TLS turns out to be an essential event for the HAT inhibitory activity. A key consensus sequence of the pncRNA is composed of GGUG, while not every RNA sequence bearing GGUG is targeted by TLS, suggesting that a secondary structure of the GGUG-bearing RNAs is also involved in recognition by TLS. Taken together, TLS is a unique mediator between signals of the long ncRNAs and transcription, suggesting that RNA networking functions in living cells.1–3


These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pawlicki JM, Steitz JA. Nuclear networking fashions premessenger RNA and primary microRNA transcripts for function. Trends Cell Biol 2009; 20:52–61.PubMedCrossRefGoogle Scholar
  2. 2.
    Collins LJ, Penny D. The RNA infrastructure: dark matter of the eukaryotic cell? Trends Genet 2009; 25:120–128.PubMedCrossRefGoogle Scholar
  3. 3.
    Siomi H, Siomi MC. On the road to reading the RNA-interference code. Nature 2009; 457:396–404.PubMedCrossRefGoogle Scholar
  4. 4.
    ENCODE-consortium. The ENCODE (ENCyclopedia OfDNA Elements) Project. Science 2004; 306:636–640.CrossRefGoogle Scholar
  5. 5.
    Carninci P, Kasukawa T, Katayama S et al. The transcriptional landscape of the mammalian genome. Science 2005; 309:1559–1563.PubMedCrossRefGoogle Scholar
  6. 6.
    Bertone P, Stolc V, Royce TE et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004; 306:2242–2246.PubMedCrossRefGoogle Scholar
  7. 7.
    Willingham AT, Orth AP, Batalov S et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 2005; 309:1570–1573.PubMedCrossRefGoogle Scholar
  8. 8.
    Fire A, Xu S, Montgomery MK et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391:806–811.PubMedCrossRefGoogle Scholar
  9. 9.
    Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9:102–114.PubMedCrossRefGoogle Scholar
  10. 10.
    Lanz RB, McKenna NJ, Onate SA et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999; 97:17–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Feng J, Bi C, Clark BS et al. The Evf-2 noncoding RNA is transcribed from the Dix-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev 2006; 20:1470–1484.PubMedCrossRefGoogle Scholar
  12. 12.
    Rinn JL, Kertesz M, Wang JK et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129:1311–1323.PubMedCrossRefGoogle Scholar
  13. 13.
    Yu W, Gius D, Onyango P et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008; 451:202–206.PubMedCrossRefGoogle Scholar
  14. 14.
    Wang X, Arai S, Song X et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008; 454:126–130.PubMedCrossRefGoogle Scholar
  15. 15.
    Crozat A, Aman P, Mandahl N et al. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993; 363:640–644.PubMedCrossRefGoogle Scholar
  16. 16.
    Kuroda M, Sok J, Webb L et al. Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J2000; 19:453–462.PubMedCrossRefGoogle Scholar
  17. 17.
    Hicks GG, Singh N, Nashabi A et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 2000; 24:175–179.PubMedCrossRefGoogle Scholar
  18. 18.
    Delattre O, Zucman J, Plougastel B et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359:162–165.PubMedCrossRefGoogle Scholar
  19. 19.
    Bertolotti A, Lutz Y, Heard DJ et al. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 1996; 15:5022–5031.PubMedGoogle Scholar
  20. 20.
    Bertolotti A, Bell B, Tora L. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties. Oncogene 1999; 18:8000–8010.PubMedCrossRefGoogle Scholar
  21. 21.
    Attwooll C, Tariq M, Harris M et al. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene 1999; 18:7599–7601.PubMedCrossRefGoogle Scholar
  22. 22.
    Ladanyi M. The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 1995; 4:162–173.PubMedCrossRefGoogle Scholar
  23. 23.
    Riggi N, Cironi L, Provero P et al. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 2006; 66:7016–7023.PubMedCrossRefGoogle Scholar
  24. 24.
    Lerga A, Hallier M, Delva L et al. Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 2001; 276:6807–6816.PubMedCrossRefGoogle Scholar
  25. 25.
    Miyakawa Y, Matsushime H. Rapid downregulation of cyclin D1 mRNA and protein levels by ultraviolet irradiation in murine macrophage cells. Biochem Biophys Res Commun 2001; 284:71–76.PubMedCrossRefGoogle Scholar
  26. 26.
    Guttman M, Amit I, Garber M et al. Chromatin signature reveals over a thousand highly conserved large noncoding RNAs in mammals. Nature 2009; 458:223–227.PubMedCrossRefGoogle Scholar
  27. 27.
    Khalil AM, Guttman M, Huarte M et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009; 106:11667–11672.PubMedCrossRefGoogle Scholar
  28. 28.
    Huarte M, Guttman M, Feldser D et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142:409–419.PubMedCrossRefGoogle Scholar
  29. 29.
    Iko Y, Kodama TS, Kasai N et al. Domain architectures and characterization of an RNA-binding protein, TLS. J Biol Chem 2004; 279:44834–44840.PubMedCrossRefGoogle Scholar
  30. 30.
    Kapranov P, Cheng J, Dike S et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007; 316:1484–1488.PubMedCrossRefGoogle Scholar
  31. 31.
    Wang P, Yin S, Zhang Z et al. Evidence for common short natural trans sense-antisense pairing between transcripts from protein coding genes. Genome Biol 2008; 9:R169.PubMedCrossRefGoogle Scholar
  32. 32.
    Zinszner H, Albalat R, Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 1994; 8:2513–2526.PubMedCrossRefGoogle Scholar
  33. 33.
    Prasad DD, Ouchida M, Lee L et al. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 1994; 9:3717–3729.PubMedGoogle Scholar
  34. 34.
    Loughlin FE, Mansfield RE, Vaz PM et al. The zinc fingers of the SR-like protein ZRANB2 are single-stranded RNA-binding domains that recognize 5′ splice site-like sequences. Proc Natl Acad Sci USA 2009; 106:5581–5586.PubMedCrossRefGoogle Scholar
  35. 35.
    Martianov I, Ramadass A, Serra Barros A et al. Repression of the human dihydrofolate reductase gene by a noncoding interfering transcript. Nature 2007; 445:666–670.PubMedCrossRefGoogle Scholar
  36. 36.
    Kim TK, Hemberg M, Gray JM et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465:182–187.PubMedCrossRefGoogle Scholar
  37. 37.
    Ayoubi TA, Van De Ven WJ. Regulation of gene expression by alternative promoters. FASEB J 1996; 10:453–460.PubMedGoogle Scholar
  38. 38.
    Martens JA, Laprade L, Winston F. Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature 2004; 429:571–574.PubMedCrossRefGoogle Scholar
  39. 39.
    Impey S, McCorkle SR, Cha-Molstad H et al. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 2004; 119:1041–1054.PubMedGoogle Scholar
  40. 40.
    An W, Kim J, Roeder RG. Ordered cooperative functions of PRMT1, p300 and CARM1 in transcriptional activation by p53. Cell 2004; 117:735–748.PubMedCrossRefGoogle Scholar
  41. 41.
    Kurokawa R, Rosenfeld MG, Glass CK. Transcriptional regulation through noncoding RNAs and epigenetic modifications. RNA Biol 2009; 6:233–236.PubMedCrossRefGoogle Scholar
  42. 42.
    Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323:1205–1208.PubMedCrossRefGoogle Scholar
  43. 43.
    Vance C, Rogelj B, Hortobágyi T et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323:1208–1211.PubMedCrossRefGoogle Scholar
  44. 44.
    Van Langenhove T, van der Zee J, Sleegers K et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 2010; 74:366–371.PubMedCrossRefGoogle Scholar
  45. 45.
    Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell 2009; 136:1001–1004.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Riki Kurokawa
    • 1
  1. 1.Division of Gene Structure and Function, Research Center for Genomic MedicineSaitama Medical UniversitySaitama-KenJapan

Personalised recommendations